Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells.
about
Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients.Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.Antigen-specific primed cytotoxic T cells eliminate tumour cells in vivo and prevent tumour development, regardless of the presence of anti-apoptotic mutations conferring drug resistance.Activated human primary NK cells efficiently kill colorectal cancer cells in 3D spheroid cultures irrespectively of the level of PD-L1 expression.
P2860
Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Activated Allogeneic NK Cells ...... ic Lymphocytic Leukemia Cells.
@en
Activated Allogeneic NK Cells ...... ic Lymphocytic Leukemia Cells.
@nl
type
label
Activated Allogeneic NK Cells ...... ic Lymphocytic Leukemia Cells.
@en
Activated Allogeneic NK Cells ...... ic Lymphocytic Leukemia Cells.
@nl
prefLabel
Activated Allogeneic NK Cells ...... ic Lymphocytic Leukemia Cells.
@en
Activated Allogeneic NK Cells ...... ic Lymphocytic Leukemia Cells.
@nl
P2093
P2860
P50
P356
P1476
Activated Allogeneic NK Cells ...... nic Lymphocytic Leukemia Cells
@en
P2093
Alberto Anel
Aura Muntasell
Diego Sánchez-Martínez
Elisa Cisneros
Gemma Azaceta
José A García Marco
Luis Martínez-Lostao
Luis Palomera
Manuela Moraru
Natalia Gómez
P2860
P356
10.3389/FIMMU.2016.00454
P577
2016-10-27T00:00:00Z